Evidence map›Paper›PMID 24740792›Full record

ArticleAmerican journal of physiology. Renal physiology2014

Mesangial cell αvβ8-integrin regulates glomerular capillary integrity and repair.

Sujata Lakhe-Reddy, Vincent Li, Thomas D Arnold, Shenaz Khan, Jeffrey R Schelling

Abstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Integrins in the kidney - beyond the matrix.Nature reviews. Nephrology · 2025
    Review
  4. Review
  5. Review
  6. Article
  7. Recessive Mutations inKidney international reports · 2021
    Article
  8. Article
  9. Review
  10. Thrombospondin-1 regulation of latent TGF-β activation: A therapeutic target for fibrotic disease.Matrix biology : journal of the International Society for Matrix Biology · 2018
    Review
  11. The Role of YB1 in Renal Cell Carcinoma Cell Adhesion.International journal of medical sciences · 2018
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Sujata Lakhe-ReddyDepartment of Medicine, Case Western Reserve University, Rammelkamp Center for Research, MetroHealth Medical Center, Cleveland, Ohio; and.
Vincent LiDepartment of Medicine, Case Western Reserve University, Rammelkamp Center for Research, MetroHealth Medical Center, Cleveland, Ohio; and.
Thomas D ArnoldDepartment of Pediatrics, University of California, San Francisco, California.
Shenaz KhanDepartment of Medicine, Case Western Reserve University, Rammelkamp Center for Research, MetroHealth Medical Center, Cleveland, Ohio; and.
Jeffrey R SchellingDepartment of Medicine, Case Western Reserve University, Rammelkamp Center for Research, MetroHealth Medical Center, Cleveland, Ohio; and jeffrey.schelling@case.edu.
MetroHealth Medical Center · USCase Western Reserve University · USUniversity of California, San Francisco · US

Funding

Mechanisms of tubular atrophy in renal diseaseR01DK067528 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI SCHELLING, JEFFREY R · 2005 to 2025
$7.1M
Mechanisms of glomerular disesase progressionR01DK072348 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI SCHELLING, JEFFREY R · 2008 to 2012
$1.6M
NIDDK NIH HHS R01-DK-067528NIDDK NIH HHS R01 DK072348NIDDK NIH HHS R01-DK-072348
6 · The paper itself

Abstract

αvβ8-Integrin is most abundantly expressed in the kidney, brain, and female reproductive organs, and its cognate ligand is latent transforming growth factor (LTGF)-β. Kidney αvβ8-integrin localizes to mesangial cells, and global β8-integrin gene (Itgb8) deletion results in embryonic lethality due to impaired placentation and cerebral hemorrhage. To circumvent the lethality and better define kidney αvβ8-integrin function, Cre-lox technology was used to generate mesangial-specific Itgb8-null mice. Platelet-derived growth factor-β receptor (PDGFBR)-Cre mice crossed with a reporter strain revealed functional Cre recombinase activity in a predicted mesangial pattern. However, mating between two different PDGFBR-Cre or Ren1(d)-Cre strains with Itgb8 (flox/-) mice consistently resulted in incomplete recombination, with no renal phenotype in mosaic offspring. Induction of a renal phenotype with Habu snake venom, a reversible mesangiolytic agent, caused exaggerated glomerular capillary microaneurysms and delayed recovery in Cre(+/-) PDGFRB (flox/-) mice compared with Cre(+/-) PDGFRB (flox/+) control mice. To establish the mechanism, in vitro experiments were conducted in Itgb8-null versus Itgb8-expressing mesangial cells and fibroblasts, which revealed β8-integrin-regulated adhesion to Arg-Gly-Asp (RGD) peptides within a mesangial-conditioned matrix as well as β8-integrin-dependent migration on RGD-containing LTGF-β or vitronectin matrices. We speculate that kidney αvβ8-integrin indirectly controls glomerular capillary integrity through mechanical tension generated by binding RGD peptides in the mesangial matrix, and healing after glomerular injury may be facilitated by mesangial cell migration, which is guided by transient β8-integrin interactions with RGD ligands.

Indexed as

AnimalsCapillariesCell MovementCells, CulturedFemaleIntegrinsIn Vitro TechniquesKidney GlomerulusMaleMechanotransduction, CellularMesangial CellsMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicModels, Animalarginyl-glycyl-aspartic acidintegrin alphavbeta8IntegrinsOligopeptidesReceptor, Platelet-Derived Growth Factor betacell migrationextracellular matrixglomerular endothelial cellglomerular injury

Identifiers

PMID24740792
PMCPMC4059974
OpenAlexW2151189313

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.